Ernawati, Yuli and , Dr. dr. EM. Sutrisna, M.Kes and , Tanti Azizah Sujono, M.Sc., Apt (2016) Analisis Efektivitas Biaya Penggunaan Antihipertensi Kombinasi Dua Obat Pada Pasien Hipertensi Rawat Jalan Di Rumah Sakit Umum Daerah Dr. Moewardi Tahun 2012. Skripsi thesis, Universitas Muhammadiyah Surakarta.
![[img]](http://eprints.ums.ac.id/style/images/fileicons/application_pdf.png) |
PDF (NASKAH PUBLIKASI)
NASKAH PUBLIKASI.pdf Download (1MB) |
|
PDF (HALAMAN DEPAN)
HALAMAN DEPAN.pdf Download (245kB) |
|
PDF (BAB I)
BAB 1.pdf Download (137kB) |
|
PDF (BAB II)
BAB 2.pdf Restricted to Repository staff only Download (100kB) |
|
PDF (BAB III)
BAB 3.pdf Restricted to Repository staff only Download (229kB) |
|
PDF (BAB IV)
BAB 4.pdf Restricted to Repository staff only Download (26kB) |
|
PDF (DAFTAR PUSTAKA)
DAFTAR PUSTAKA.pdf Download (35kB) |
|
PDF (LAMPIRAN)
LAMPIRAN.pdf Restricted to Repository staff only Download (628kB) |
|
PDF (SURAT PERNYATAAN PUBLIKASI)
SURAT PERNYATAAN PUBLIKASI.pdf Restricted to Repository staff only Download (61kB) |
Abstract
Hypertension is one of the major factors of risk of death from cardiovascular disorders that result in 20-50% of all deaths. Health financing in Indonesia increase, the cost-effectiveness analysis is needed in order to assist in decision making these medicines are effective benefits and cost. This study aims to determine the antihypertensive combination of the most cost-effective in the Hospital Dr. Moewardi in 2012. This study is a non-experimental descriptive. The data collection was done retrospectively based on medical records, laboratory and administrative price ceilings on drugs. Cost-effectiveness analysis was done by comparing large direct medical costs on average per month against the percentage of patients reaching blood pressure targets based on parameter ACER. The results showed 8 pattern combinations used patient is beta blockers with ACE-inhibitor, ARBs with hidrochlorothiazid, ARB with CCB, ARB with beta blockers, ACE-inhibitor with diuretics hidrochlorothiazid, ACE-inhibitors with furosemide, ACE-inhibitorwith ARBs, ACE -Inhibitor with CCB. The pattern of treatment which is the most cost-effective for patients with hypertension based on effectiveness of decreasing blood pressure to reach the target was with ACE-inhibitors with hidrochlorothiazid with amounted490,69 ACER and ICER -13.663,68.
| Item Type: | Karya ilmiah (Skripsi) |
|---|---|
| Uncontrolled Keywords: | hypertension, outpatient, cost-effetiveness analysis |
| Subjects: | R Medicine > RS Pharmacy and materia medica |
| Divisions: | Fakultas Farmasi > Farmasi |
| Depositing User: | YULI ERNAWATI |
| Date Deposited: | 15 Oct 2016 05:25 |
| Last Modified: | 15 Oct 2016 05:25 |
| URI: | http://eprints.ums.ac.id/id/eprint/46790 |
Actions (login required)
 |
View Item |
